Innate Pharma S.A. IPHYF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.45M | 12.56M | 40.28M | 40.26M | 70.50M |
| Total Receivables | 5.24M | 5.29M | 8.94M | 8.93M | 1.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.13M | 2.15M | 2.80M | 2.80M | 2.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.58M | 2.60M | 2.82M | 2.82M | 1.87M |
| Total Current Assets | 22.39M | 22.60M | 54.84M | 54.80M | 76.31M |
|
|
|||||
| Total Current Assets | 22.39M | 22.60M | 54.84M | 54.80M | 76.31M |
| Net Property, Plant & Equipment | 4.16M | 4.20M | 5.11M | 5.11M | 5.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.15M | 1.16M | 1.41M | 1.41M | 14.81M |
| Total Assets | 39.67M | 40.04M | 73.64M | 73.59M | 109.15M |
|
|
|||||
| Total Accounts Payable | 6.20M | 6.26M | 8.78M | 8.77M | 5.34M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.33M | 12.44M | 10.33M | 10.33M | 10.49M |
| Total Finance Division Other Current Liabilities | 19.01M | 19.18M | 23.92M | 23.90M | 18.72M |
| Total Other Current Liabilities | 19.01M | 19.18M | 23.92M | 23.90M | 18.72M |
| Total Current Liabilities | 37.54M | 37.88M | 43.03M | 43.00M | 34.56M |
|
|
|||||
| Total Current Liabilities | 37.54M | 37.88M | 43.03M | 43.00M | 34.56M |
| Long-Term Debt | 10.71M | 10.81M | 16.05M | 16.04M | 21.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.30K | 50.70K | 113.90K | 113.80K | 177.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.66M | 38.01M | 39.92M | 39.90M | 47.30M |
| Total Liabilities | 85.95M | 86.75M | 99.12M | 99.05M | 103.10M |
|
|
|||||
| Common Stock & APIC | 472.74M | 477.10M | 484.58M | 484.24M | 483.45M |
| Retained Earnings | -520.01M | -524.81M | -511.38M | -511.02M | -478.81M |
| Treasury Stock & Other | 988.20K | 997.30K | 1.31M | 1.31M | 1.40M |
| Total Common Equity | -46.28M | -46.71M | -25.48M | -25.47M | 6.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.28M | -46.71M | -25.48M | -25.47M | 6.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -46.28M | -46.71M | -25.48M | -25.47M | 6.04M |
|
|
|||||